Reactions to awareness of activated protein C resistance carriership: A descriptive study of 270 women

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 5, 2003, Pages 467-470

  Lindqvist, Pelle G ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APC resistance; Combined oral contraceptives; Leiden mutation; Thrombophilia testing

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; AWARENESS; CAUCASIAN; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PREGNANCY; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ATTITUDE TO HEALTH; AWARENESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; QUESTIONNAIRES; SWEDEN; UTERINE HEMORRHAGE; WOMEN'S HEALTH;

EID: 0037901100     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00118.x     Document Type: Article

References (5)

1. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998; 24: 367-79.
2. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-17.
3. Dahlbäck B. APC resistance, oral contraceptives and thrombosis. Screening is justified for diagnosing high-risk cases. Läkartidningen 1997; 94: 1522-4.
4. Milsom I, Odlind V. P pills and APC resistance. General screening is not justified. Läkartidningen 1997; 94: 1208-9.
5. Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Lutherkort M, Dahlbäck B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.